February 21st 2024
A panel of medical experts discuss key highlights from ASCO GI 2024 surrounding the hepatocellular carcinoma (HCC) treatment landscape.
January 9th 2024
Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss current and emerging treatment landscape of chronic graft-versus-host disease (GVHD). They examine treatment selection in different lines of therapies and the near future landscape of treatment when newer mechanisms of action become available for GVHD.
December 14th 2023
December 13th 2023
A panel of experts discuss recent data updates on the treatment and management of HER2+ breast cancer and how these data may impact practice.
A panel of hematologist-oncologists provides an overview of the diagnosis and treatment of myelodysplastic syndromes (MDS) and offers comprehensive insights on the evolving treatment landscape.
A team of expert oncologists delves into the latest developments in treating AL amyloidosis, placing particular emphasis on innovative therapies aimed at targeting amyloid deposits.
A panel of experts discuss recent updates including new data from ASH 2023 on the treatment of follicular lymphoma and mantle cell lymphoma as well as their clinical implications.
Experts discuss several recent data updates in polycythemia vera and myelofibrosis in the context of the treatment landscape and its impact on clinical practice.
A panel of expert oncologists explore advancements in the treatment of CLL, reviewing recent data updates from ASH 2023 and their potential impact on clinical practice.
A panel of expert oncologists explore recent advancements in the treatment of desmoid tumors, highlighting the approval of nirogacestat as the first FDA-approved in this treatment setting, and discussing its impact on clinical practice.
November 16th 2023
Expert panelists review recent advances in biomarker testing and the treatment landscape of uncommon EGFR mutations in non–small cell lung cancer.
October 31st 2023
A panel of experts on advanced non–small cell lung cancer discuss the overall treatment landscape and look at recent data in the context of clinical guidelines.
A panel of experts in gynecologic oncology explore advancements in the treatment of endometrial and cervical cancers, including breaking clinical trial data from ESMO 2023, and their potential impact on clinical practice.
A panel of experts discusses updates in metastatic melanoma biomarker testing and treatment presented at ESMO Congress 2023 and other recent meetings and reviews the data in the context of existing guidelines, the current treatment landscape, and its impact on clinical practice.
October 30th 2023
Expert panelists review recent updates in the treatment of advanced RCC following recent updates from the ESMO 2023 annual meeting and consider how they would approach specific scenarios in clinic.
September 29th 2023
A panel of medical oncologists, nurse practitioners, and nurses specializing in breast, lung, and gastric cancers have a comprehensive discussion on antibody-drug conjugates, molecular testing, and best practices for treating patients.
August 21st 2023
Expert panelists highlight some of the most critical unmet needs in multiple myeloma and consider how to provide optimal care for patients globally.
